Results Preview: Scrip's Pharma Watchlist
This article was originally published in Scrip
Johnson & Johnson will kick off the big pharma financial results season on Jan. 26. The backdrop for the company's conference call on its earnings will be the restructuring of its medical devices business. On Jan. 19 it announced it would cut around 3,000 jobs to make savings of $800m-1bn. That will involve one-off charges of $2-2.4bn with about $600m to be lodged in the books of the fourth quarter just gone. J&J has promised additional details of the impact of its changes during its earnings call.
Register for our free email digests: